Australia markets open in 4 hours 46 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.20-1.07 (-2.54%)
As of 03:14PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
125,983
106,140
101,418
112,512
106,011
-
Depreciation & amortisation
938
2,362
3,446
3,476
2,237
-
Deferred income taxes
-33,655
-29,493
-33,905
4,346
14,089
-
Stock-based compensation
54,397
48,940
42,442
42,931
33,539
-
Change in working capital
-12,100
8,218
5,539
-466
-5,357
-
Accounts receivable
-21,284
-10,066
-3,432
-1,427
-6,270
-
Inventory
-913
1,265
1,199
3,444
-3,514
-
Accounts payable
11,309
5,778
4,757
-3,597
3,161
-
Other working capital
123,281
126,900
119,910
167,423
150,732
-
Other non-cash items
-
-
1,383
10
1,451
-1,738
Net cash provided by operating activities
123,734
127,039
120,323
167,892
151,970
-
Cash flows from investing activities
Investments in property, plant and equipment
-453
-139
-413
-469
-1,238
-
Purchases of investments
-460,537
-328,748
-355,066
-312,805
-420,114
-
Sales/maturities of investments
299,310
419,793
241,152
449,400
302,089
-
Net cash used for investing activities
-161,680
90,906
-114,327
136,126
-119,263
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
0
Common stock repurchased
0
-145,428
0
-295,985
-9,945
-
Other financing activities
-9,719
-9,106
-21,665
-22,835
-1,067
-
Net cash used provided by (used for) financing activities
-5,843
-148,723
-17,284
-302,591
12,214
-
Net change in cash
-43,789
69,222
-11,288
1,427
44,921
-
Cash at beginning of period
172,377
66,329
77,617
76,190
31,269
-
Cash at end of period
128,588
135,551
66,329
77,617
76,190
-
Free cash flow
Operating cash flow
123,734
127,039
120,323
167,892
151,970
-
Capital expenditure
-453
-139
-413
-469
-1,238
-
Free cash flow
123,281
126,900
119,910
167,423
150,732
-